Method for coating a surface of a component

Abstract
The invention relates to a method for coating a surface (44), in particular a microstructured surface, of a component (55) comprising different materials, in particular glass and silicon, wherein the surface (44) is first activated and then coated, wherein an oxidising solution, a basic solution or an acid-oxidising solution is used to activate the surface (44).
Description

The invention relates to a method for coating a surface, in particular a micro-structured surface, of a component comprising different materials, in particular glass and silicon, wherein the surface is first activated and then coated, a coated component and a nebuliser having a coated component.


WO 91/14468 A1 and WO 97/12687 A1 each show a nebuliser which is marketed in the form of an inhaler under the brand name “Respimat” by Boehringer Ingelheim Pharma GmbH & Co. KG. The nebuliser is used for propellant-free administration of a metered quantity of a liquid medicament for inhalation. In the inhaler, liquid medicament formulations are stored in a reservoir and conveyed through a riser tube into a metering chamber from which they are finally expelled through a nozzle.


The nozzle has a liquid inlet side and a liquid outlet side. On the liquid inlet side is an opening through which the liquid medicament coming from the metering chamber is able to enter the nozzle. On the opposite side, the free end face of the nozzle, the liquid then emerges through two nozzle openings which are aligned such that the jets of liquid emerging from the openings strike one another and are thereby nebulised. The nozzle openings are formed in at least two superimposed plates, at least one of which has a microstructure, so that the two plates firmly attached to one another define on one side a liquid inlet, adjoining which is a channel and/or filter system that opens into the nozzle openings. The two plates with the microstructure and the nozzle openings are referred to as a uniblock in the context of the Respimat technology.


A nebuliser of this kind usually delivers formulations based on water or water/ethanol mixtures and within a short time is able to nebulise a small amount of the liquid medicament formulation, in the therapeutically required dose, into an aerosol suitable for therapeutic inhalation. Using the nebuliser it is possible to nebulise quantities of less than 100 microliters in, for example, one actuation to form an aerosol with an average particle size of less than 20 microns, such that the inhalable part of the aerosol already corresponds to the therapeutically effective amount.


In the nebuliser with Respimat technology the medicament solution is converted by a high pressure of up to 300 bar into a slowly moving aerosol mist destined for the lungs, which can then be breathed in by the patient. In rare cases, during the use of the nebuliser, residues of the formulation solution may adhere to the nozzle outlets as a contaminant, accumulate thereon and lead to clogging of the nozzle outlets, which may be accompanied by a deflection of the jets of liquid and a change in the fine particle fraction. Even if this effect is very rare in a nebuliser of the Respimat technology, there is a need to avoid deposits for reasons of quality control.


To avoid contamination of an outer surface of the nozzle system or a mouthpiece by precipitated liquid with fine particle fractions, DE 103 00 983 A1 proposes that the corresponding surfaces should be at least partially micro- or nano-structured.


The aim of the invention is to provide a method and a component as well as a nebuliser comprising a component of the kind described hereinbefore which is of self-cleaning design with a thin functionalising coating.


According to the invention the objective is achieved by a method which uses an oxidising solution, a basic solution or an acid-oxidising solution to activate the surface.


Surprisingly, it has been found that the solutions mentioned above can be used to activate surfaces of two different materials, particularly silicon and glass, which are joined together to form a monolithic component. In the literature, a special solution is always assigned to a particular material in order to produce the reactive groups needed for interface functionalisation, as the activation has to be matched to the particular substrate and specifically developed for different materials. For example, the activation of the surface of the component is carried out using a so-called piranha solution, namely the powerfully oxidising peroxomonosulphuric acid (concentrated sulphuric acid: hydrogen peroxide solution (30%) in the ratio 7:3), at 70° C. for 20 minutes. Alternatively, RCA cleaning may be used which is normally used for wafer cleaning in microelectronics. This uses the following solution: water:ammonia solution (25%):hydrogen peroxide solution (30%), in the ratio 5:1:1. The component is exposed to the solution at 75° C. for 20 minutes.


Preferably, a cell cleaner is used as the basic solution for activating the surface. Preferably the cell or glass cleaner made by Hellma GmbH & Co. KG, of Müllheim, Germany, known under the brand name “ Hellmanex solution” is used, as an aqueous 2% solution at 70° C. for 2×20 minutes in the ultrasound bath, although the manufacturer advises against the use of ultrasound in conjunction with their “Hellmanex solution”. The Hellmanex solution ensures activation which is effective on all kinds of materials, particularly silicon and glass, in order to produce reactive interfaces.


Expediently, before being activated, the surface is cleaned, particularly with isopropanol and water. The component is immersed in isopropanol for five minutes and in water for five minutes. According to one feature, the surface is treated in a solution of hydrofluoric acid after cleaning. It is bathed for about 20 minutes in an aqueous 3% hydrofluoric acid solution (HF).


According to a further feature, functional silanes in non-polar, aprotic or polar-protic solvents are used to coat the surface. The coating is very thin and is provided as a monolayer. The component with its activated surfaces is immersed for about two hours, in a toluene reaction, in a 0.1 to 1% solution of functional trichlorosilanes or dimethylmonochlorosilanes in dry non-polar, aprotic solvents such as toluene, benzene, carbon tetrachloride, n-alkanes (C5-C10) or the like. Then the component is dried in a nitrogen current and heat-treated in an oven for about one hour at about 120° C. After the heat-treatment excess and non-covalently bound residues are washed off the component using toluene and isopropanol. When the reaction is alcoholic, particularly isopropanolic, first of all a reaction solution has to be activated in order to be able to carry out interface functionalisation of the component with its activated surfaces of silicon and glass. A 0.1 to 1% solution of functional triethoxysilanes in 2-propanol/water/hydrochloric acid (HCl) in a ratio of 90 to 98:2 to 10:0.2 to 0.5 is stirred for about five hours at ambient temperature. Then the component with its activated surfaces is immersed in the solution for about two hours. After the component has been taken out of the solution the excess solution is carefully removed from the component, for example by allowing it to drip onto an absorbent non-woven fabric. Then the component is kept at a controlled 120° C. for about two hours. Any excess and non-covalently bound residues are washed off the component using isopropanol and water after the heat treatment. The following categories of materials are used to coat the surfaces: perfluoroalkylsilanes, alkylsilanes, aminoalkylsilanes, carboxylic acid silanes, trimethylammonium silanes of different chain lengths, particularly C4-C18, while the functional silanes used may be reactive trihalosilanes (R1—Si—R3, where R═Cl, Br), monohalodimethylsilanes (R1—Si(CH3)2R, where R═Cl, Br) or trialkoxysilanes (R1—Si—R3, where R═methoxy or ethoxy groups).


To ensure satisfactory wetting of the surfaces of the component that are to be coated, in order to coat the surfaces the component is advantageously treated with ultrasound in the reaction solution. The ultrasound treatment in particular ensures the exchange of the reaction solution in the capillaries of the component.


The objective is achieved in the component comprising at least two plates firmly joined together, at least one of which has a microstructure to form a channel and/or filter system and at least one nozzle opening adjoining it, by the fact that at least the surface of the microstructure has a coating which has been applied by the method described above.


As a result of this, any interaction of components and particles of the formulation expelled through the nozzle opening with the interfaces of the component is prevented. The free energy of the surface and hence its wettability is minimised in this area, resulting in a reduction in the immobilisation of residues of material on the nozzle outlet, i.e. in the immediate vicinity of the nozzle opening. When the component is used, the residues of material are expelled from the component and the coated component is self-cleaning, thanks to the use of the monomolecular, covalently bound non-stick coating. The functionalisation can be altered variably, depending on the interaction of different ingredients of the formulation with the interfaces of the component and may, for example, have hydrophilic or hydrophobic, positively or negatively charged, oleophillic or oleophobic properties.


One plate expediently consists of silicon while the other plate is glass. The silicon plate is provided with a microstructure, i.e. it comprises the channel or filter system and the nozzle openings and is adhesively bonded to the plate made of glass.


The component consists of the two plates of glass and silicon firmly joined together, while the plate consisting of silicon has one or more microstructured channels which connect the inlet side to the outlet side. On the outlet side there may be at least one round or non-round nozzle opening 2-10 μm deep and 5-15 μm wide, the depth preferably being 4.5 to 6.5 μm and the length being 7 to 9 μm. In the case of a plurality of nozzle openings, preferably two, the directions of flow through the nozzles in the component which essentially forms a nozzle body extend parallel to one another or are inclined towards one another in the direction of the nozzle opening. In a component having at least two nozzle openings on the outlet side, the directions of flow may slope towards one another at an angle of 20° to 160°, preferably at 60° to 150°, more preferably 70° to 100°. The nozzle openings are preferably arranged at a distance of 10 to 200 μm, more preferably at a distance of 10 to 100 μm, particularly preferably 30 to 70 μm. A distance of 50 μm is most preferred. The directions of flow meet accordingly in the vicinity of the nozzle openings. In the interests of simplicity an embodiment will be described hereinafter in which only the silicon plate of the component has relief-like microstructures, but not the plate made of glass. In other embodiments the situation is exactly the reverse, or both plates comprise these microstructures. On the silicon plate, a set of channels may be formed on the flat surface in order to create a plurality of filter passages (filter channels) in co-operation with the substantially flat surface of the glass plate. Additionally, the silicon plate may have a plenum chamber the ceiling of which is in turn formed by the glass plate. The plenum chamber may be provided in front of or behind the filter channels. It is also possible to have two such plenum chambers. Another set of channels on the substantially flat surface of the silicon plate which is provided after the filter channels forms, together with the glass plate, a set of channels that provide a plurality of nozzle outlet passages. Preferably, the total cross-sectional area of the nozzle outlets is 25 to 500 μm2. The entire cross-sectional area is preferably 30 to 200 μm2. In another embodiment this nozzle construction also has only a single nozzle opening. In other embodiments of this kind the filter channels and/or the plenum chamber are omitted. Preferably, the filter channels are formed by projections arranged in a zig-zag configuration. Thus, for example, at least two rows of the projections form a zig-zag configuration of this kind. A number of rows of projections may also be formed, the projections being laterally offset from one another in order to form additional rows that are skewed in relation to these rows, these additional rows mentioned above then forming the zig-zag configuration. In such embodiments the inlet and outlet may each comprise a longitudinal slot for unfiltered or filtered fluid, each of the slots being substantially the same width as the filter and substantially the same height as the projections on the inlet and outlet sides of the filter. The cross-section of the passages formed by the projections may be perpendicular to the direction of flow of the fluid and may decrease from one row to the next, viewed in the direction of flow. Also, the projections that are arranged closer to the inlet side of the filter may be larger than the projections that are arranged closer to the outlet side of the filter. In addition, the spacing between the silicon plate and the glass plate may become narrower in the region from the inlet side to the outlet side. The zig-zag configuration which is formed by at least two rows of projections has an angle of inclination of preferably 20° to 250°. Further details of this construction of the component can be found in WO 94/07607.


Finally, the objective is achieved with a nebuliser for delivering a specific amount of a fluid, in particular a fluid containing a medicament, as an aerosol, using the component of the kind described hereinbefore.


It will be understood that the features mentioned above and those to be explained hereinafter may be used not only in the particular combinations stated but also in other combinations. The scope of the invention is defined only by the claims.





The invention is hereinafter described in more detail by means of an embodiment by way of example, by reference to the attached drawings, wherein:



FIG. 1 is a longitudinal section through a nebuliser according to the invention with a tensioned spring,



FIG. 2 is a longitudinal section through the nebuliser according to FIG. 1 with the spring relaxed,



FIG. 3 is a perspective view of a component according to the invention,



FIG. 4 is a front view of the component according to FIG. 3 and



FIG. 5 is a magnified partial representation of the component according to FIG. 3.





An upper housing part 51 of the nebuliser comprises a pump housing 52 on the end of which is mounted a holder 53 for a nebuliser nozzle. In the holder 53 is a recess 54 that widens outs and the component 55 in the form of a nozzle body. A hollow piston fixed in a power take-off flange 56 of a locking clamping mechanism projects partly into a cylinder of the pump housing 52. At its end the hollow piston 57 carries a valve body 58. The hollow piston 57 is sealed off by a gasket 59. Inside the upper housing part 51 is a stop 60 of the power take-off flange 56 on which a compression spring 68 rests. After the tensioning of the compression spring 68 a locking member 62 slides between a stop 61 on the power take-off flange 56 and a support 63 in the upper housing part 51. An actuating button 64 is connected to the locking member 62. The upper housing part 51 ends in a mouthpiece 65 and is closed off by a removable protective cap 66.


A spring housing 67 with the compression spring 68 is rotatably mounted on the upper housing part 51 by means of snap-fit lugs 69 and a rotary bearing. A lower housing part 70 is pushed over the spring housing 67 and inside the spring housing 67 is a storage container 71 for fluid 72 which is to be nebulised. The storage container 71 is closed off by a stopper 73 through which the hollow piston 57 projects into the storage container 71 and dips its end into the fluid 72, i.e. the supply of active substance solution.


A spindle 74 for a mechanical counter (optional) is provided in an outer surface of the spring housing 67. A drive pinion 75 is located at the end of the spindle 74 facing the upper housing part 51. On the spindle 74 is a slider 76.


The component 55—a so-called uniblock—comprises two plates 40, 41 firmly joined together, of which one plate 40 is made of silicon and has a microstructure 42 for forming a channel or filter system and an adjacent nozzle opening 43. The silicon plate 40 is firmly attached to the glass plate 41 on the side having the microstructure 42.


At least the surface 44 of the microstructure 42 has a coating consisting of functional silanes which prevents any interaction of ingredients and particles of the formulation expelled through the nozzle opening 43 with the interfaces of the component 55. During the use of the nebuliser comprising the component 55, the material residues are expelled from the component 55 and the coated component 55 is self-cleaning thanks to the use of the monomolecular, covalently bound non-stick coating.


The surfaces 44 of the component 55, particularly the microstructure 42, are first cleaned by dipping the component 5 first into isopropanol for five minutes and then into water for five minutes. Then the component 55 is bathed for about 20 minutes in an aqueous 3% hydrofluoric acid solution (HF).


The activation of the surface 44 itself is carried out using a cell cleaner, particularly the cell or glass cleaner known by the brand name “Hellmanex solution” and produced by Hellma GmbH & Co. KG, of Müllheim, Germany, as an aqueous 2% solution, at 70° C. for 2×20 minutes in an ultrasound bath.


For functionalisation, 1H,1H,2H,2H-perfluorooctyltriethoxysilane is used, for example, which is marketed for example under the brand name Dynasylan by Evonik AG of Düsseldorf. After the component 55 has been exposed for about two hours to a solution containing the functional silane under the effect of ultrasound, the excess solution is allowed to drip off the component 55 and the component is treated for about one to two hours at 120° C. in an oven. After the heat treatment any excess and non-covalently bound residues are washed off the component 55 using isopropanol and water.

Claims
  • 1. A method for preparing a nebulizer, the method comprising: coating a microstructured surface within a component comprising glass and silicon, wherein the component consists of a plate of glass and a plate of silicon firmly joined together and at least one of the plates has one or more microstructured channels, wherein the surface is first activated and then coated, characterized in that:an oxidizing solution, a basic solution or an acid-oxidizing solution is used to activate the surface,before the activation the surface is cleaned, andcoating the surface comprises: applying a reaction solution to coat the microstructured channels, the reaction solution comprising functional silanes in non-polar, aprotic or polar-protic solvents, andtreating the microstructured surface with ultrasound during application of the reaction solution, wherein the ultrasound treatment causes flow of the reaction solution into the microstructured channels; and incorporating the component into a medical device configured to nebulize a liquid medicament passed through the one or more microstructured channels.
  • 2. The method according to claim 1, characterized in that the coated component is washed.
  • 3. The method according to claim 1, wherein the oxidizing solution which is used for activating the surface is a solution consisting of water, ammonia solution, containing 25% ammonia, and hydrogen peroxide solution, containing 30% hydrogen peroxide, in the ratio 5:1:1.
  • 4. The method according to claim 1, wherein a piranha solution is used as an acid-oxidizing solution for activating the surface.
  • 5. The method according to claim 1, wherein before the activation the surface is cleaned using isopropanol and water.
  • 6. The method according to claim 1, wherein for coating the surface, perfluoroalkylsilanes or alkylsilanes are used.
  • 7. The method according to claim 6, wherein for coating the surface perfluoroalkl silanes or trialkoxysilanes are used.
  • 8. The method according to claim 1, wherein for coating the surface, trihalosilanes, monohalodimethylsilanes or trialkoxysilanes are used.
  • 9. The method according to claim 8, wherein dimethylmonochlorosilanes in dry non-polar, aprotic solvents are used for coating.
  • 10. The method according to claim 9, wherein for coating the component is immersed in a solution of dimethylmonochlorosilanes and then dried in a nitrogen current.
  • 11. The method according to claim 8, wherein a solution of trialkoxysilanes is used for coating.
  • 12. The method according to claim 11, wherein a 0.1 to 1% solution of functional triethoxysilanes in 2-ropanol/water/hydrochloric acid is stirred for about five hours and the component with its activated surfaces is then immersed in the solution.
  • 13. The method according to claim 11, wherein after the component has been taken out of the solution, the excess solution is removed from the component by allowing it to drip.
  • 14. The method according to claim 11, wherein the trialkoxysilanes used are trimethoxysilanes or triethoxysilanes.
  • 15. The method according to claim 1, wherein after the coating the component is heat-treated.
  • 16. The method according to claim 15, wherein after the coating the component is heat-treated for 1 to 2 hours at 120° C.
  • 17. The method according to claim 1, wherein the reaction solution forms a coating layer on the one or more microstructured channels, and wherein the coating layer inhibits accumulation of a liquid medicament within the one or more microstructured channels.
Priority Claims (1)
Number Date Country Kind
09156940 Mar 2009 EP regional
PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/EP2010/053668 3/22/2010 WO 00 11/7/2011
Publishing Document Publishing Date Country Kind
WO2010/112358 10/7/2010 WO A
US Referenced Citations (496)
Number Name Date Kind
1828864 Hopkins Oct 1931 A
2015970 Schoene Oct 1935 A
2127401 Gillican Aug 1938 A
2161071 McGrath et al. Jun 1939 A
2321428 Schloz Jun 1943 A
2329311 Waters Sep 1943 A
2362103 Smith Nov 1944 A
2651303 Johnson et al. Sep 1953 A
2720969 Kendall Oct 1955 A
2793776 Lipari May 1957 A
2974880 Stewart et al. Mar 1961 A
3032823 Sherman et al. May 1962 A
3157179 Allen et al. Nov 1964 A
3172568 Modderno Mar 1965 A
3196587 Hayward et al. Jul 1965 A
3223289 Bouet Dec 1965 A
3299603 Shaw Jan 1967 A
3354883 Southerland Nov 1967 A
3440144 Anderson et al. Apr 1969 A
3457694 Tatibana Jul 1969 A
3491803 Galik Jan 1970 A
3502035 Fedit Mar 1970 A
3580249 Takaoka May 1971 A
3590557 Vogel Jul 1971 A
3632743 Geller et al. Jan 1972 A
3655096 Easter Apr 1972 A
3674060 Ruekberg Jul 1972 A
3675825 Morane Jul 1972 A
3802604 Morane et al. Apr 1974 A
3820698 Franz Jun 1974 A
3842836 Ogle Oct 1974 A
3858580 Ogle Jan 1975 A
3861851 Schiemann Jan 1975 A
3870147 Orth Mar 1975 A
3924741 Kachur et al. Dec 1975 A
3933279 Maier Jan 1976 A
3946732 Hurscham Mar 1976 A
3949751 Birch et al. Apr 1976 A
3951310 Steiman Apr 1976 A
3953995 Haswell et al. May 1976 A
3973603 Franz Aug 1976 A
4012472 Lindsey Mar 1977 A
4031892 Hurschman Jun 1977 A
4036439 Green Jul 1977 A
4048997 Raghavachari et al. Sep 1977 A
4067499 Cohen Jan 1978 A
4094317 Wasnich Jun 1978 A
4120995 Phipps et al. Oct 1978 A
4126559 Cooper Nov 1978 A
4153689 Hirai et al. May 1979 A
4174035 Wiegner Nov 1979 A
4177938 Brina Dec 1979 A
4178928 Tischlinger Dec 1979 A
4195730 Hunt Apr 1980 A
4245788 Wright Jan 1981 A
4275840 Staar Jun 1981 A
4315570 Silver et al. Feb 1982 A
4338765 Ohmori et al. Jul 1982 A
4377106 Workman et al. Mar 1983 A
4456016 Nowacki et al. Jun 1984 A
4467965 Skinner Aug 1984 A
4476116 Anik Oct 1984 A
4515586 Mendenhall et al. May 1985 A
4516967 Kopfer May 1985 A
4603794 DeFord et al. Aug 1986 A
4677975 Edgar et al. Jul 1987 A
4727985 McNeirney et al. Mar 1988 A
4749082 Gardiner et al. Jun 1988 A
4796614 Nowacki et al. Jan 1989 A
4805377 Carter Feb 1989 A
4813210 Masuda et al. Mar 1989 A
4821923 Skorka Apr 1989 A
4840017 Miller et al. Jun 1989 A
4863720 Burghart et al. Sep 1989 A
4868582 Dreinhoff Sep 1989 A
4885164 Thurow Dec 1989 A
4905450 Hansen et al. Mar 1990 A
4926613 Hansen May 1990 A
4951661 Sladek Aug 1990 A
4952310 McMahan et al. Aug 1990 A
4964540 Katz Oct 1990 A
RE33444 Lerner Nov 1990 E
4973318 Holm et al. Nov 1990 A
4979941 Ogle, II Dec 1990 A
4982875 Pozzi et al. Jan 1991 A
5014492 Fiorini et al. May 1991 A
5025957 Ranalletta et al. Jun 1991 A
5059187 Sperry et al. Oct 1991 A
5060791 Zulauf Oct 1991 A
5067655 Farago et al. Nov 1991 A
5156918 Marks et al. Oct 1992 A
5174366 Nagakura et al. Dec 1992 A
5207217 Cocozza et al. May 1993 A
5230884 Evans et al. Jul 1993 A
5237797 Varlet Aug 1993 A
5246142 DiPalma et al. Sep 1993 A
5261565 Drobish et al. Nov 1993 A
5263842 Fealey Nov 1993 A
5271153 Reiboldt et al. Dec 1993 A
5282304 Reiboldt et al. Feb 1994 A
5282549 Scholz et al. Feb 1994 A
5284133 Burns et al. Feb 1994 A
5289948 Moss et al. Mar 1994 A
5339990 Wilder Aug 1994 A
5352196 Haber et al. Oct 1994 A
5380281 Tomellini et al. Jan 1995 A
5385140 Smith Jan 1995 A
5394866 Ritson et al. Mar 1995 A
5408994 Wass et al. Apr 1995 A
5433343 Meshberg Jul 1995 A
5435282 Haber et al. Jul 1995 A
5435884 Simmons et al. Jul 1995 A
5451569 Wong et al. Sep 1995 A
5456522 Beach Oct 1995 A
5456533 Streiff et al. Oct 1995 A
5472143 Bartels et al. Dec 1995 A
5482030 Klein Jan 1996 A
5487378 Robertson et al. Jan 1996 A
5497944 Weston et al. Mar 1996 A
5499750 Manifold Mar 1996 A
5499751 Meyer Mar 1996 A
5503869 Van Oort Apr 1996 A
5509404 Lloyd et al. Apr 1996 A
5518147 Peterson et al. May 1996 A
5533994 Meyer Jul 1996 A
5541569 Jang Jul 1996 A
5544646 Lloyd et al. Aug 1996 A
5547094 Bartels et al. Aug 1996 A
5569191 Meyer Oct 1996 A
5574006 Yanagawa Nov 1996 A
5579760 Kohler Dec 1996 A
5584285 Salter et al. Dec 1996 A
5593069 Jinks Jan 1997 A
5599297 Chin et al. Feb 1997 A
5603943 Yanagawa Feb 1997 A
5614172 Geimer Mar 1997 A
5622162 Johansson et al. Apr 1997 A
5622163 Jewett et al. Apr 1997 A
5643868 Weiner et al. Jul 1997 A
5662098 Yoshida Sep 1997 A
5662271 Weston et al. Sep 1997 A
5676930 Jager et al. Oct 1997 A
5685846 Michaels, Jr. Nov 1997 A
5697242 Halasz et al. Dec 1997 A
5709202 Lloyd et al. Jan 1998 A
5722598 Werding Mar 1998 A
5738087 King Apr 1998 A
5740967 Simmons et al. Apr 1998 A
5763396 Weiner et al. Jun 1998 A
5775321 Alband Jul 1998 A
5782345 Guasch et al. Jul 1998 A
5827262 Neftel et al. Oct 1998 A
5829435 Rubsamen et al. Nov 1998 A
5833088 Kladders et al. Nov 1998 A
5848588 Foley et al. Dec 1998 A
5868287 Kurokawa et al. Feb 1999 A
5871010 Datta Feb 1999 A
5881718 Mortensen et al. Mar 1999 A
5884620 Gonda et al. Mar 1999 A
5902298 Niedospial, Jr. et al. May 1999 A
5934272 Lloyd et al. Aug 1999 A
5935101 Kato et al. Aug 1999 A
5941244 Yamazaki et al. Aug 1999 A
5950016 Tanaka Sep 1999 A
5950403 Yamaguchi et al. Sep 1999 A
5951882 Simmons et al. Sep 1999 A
5964416 Jaeger et al. Oct 1999 A
5975370 Durliat Nov 1999 A
5997263 Van Lintel et al. Dec 1999 A
6041777 Faithfull et al. Mar 2000 A
6041969 Parise Mar 2000 A
6053368 Geimer Apr 2000 A
6062430 Fuchs May 2000 A
6098618 Jennings et al. Aug 2000 A
6109479 Ruckdeschel Aug 2000 A
6110247 Birmingham et al. Aug 2000 A
6116233 Denyer et al. Sep 2000 A
6119853 Garrill et al. Sep 2000 A
6120492 Finch et al. Sep 2000 A
6123068 Lloyd et al. Sep 2000 A
6131566 Ashurst et al. Oct 2000 A
6145703 Opperman Nov 2000 A
6149054 Cirrillo et al. Nov 2000 A
6152296 Shih Nov 2000 A
6171972 Mehregany et al. Jan 2001 B1
6176442 Eicher et al. Jan 2001 B1
6179118 Garrill et al. Jan 2001 B1
6186409 Srinath et al. Feb 2001 B1
6199766 Fox et al. Mar 2001 B1
6223933 Hochrainer et al. May 2001 B1
6224568 Morimoto et al. May 2001 B1
6237589 Denyer et al. May 2001 B1
6259654 de la Huerga Jul 2001 B1
6267154 Felicelli et al. Jul 2001 B1
6279786 de Pous et al. Aug 2001 B1
6302101 Py Oct 2001 B1
6315173 Di Giovanni et al. Nov 2001 B1
6319943 Joshi et al. Nov 2001 B1
6336453 Scarrott et al. Jan 2002 B1
6341718 Schilthuizen et al. Jan 2002 B1
6349856 Chastel Feb 2002 B1
6352152 Anderson et al. Mar 2002 B1
6352181 Eberhard et al. Mar 2002 B1
6363932 Forchione et al. Apr 2002 B1
6375048 van der Meer et al. Apr 2002 B1
6392962 Wyatt May 2002 B1
6395331 Yan et al. May 2002 B1
6401710 Scheuch et al. Jun 2002 B1
6401987 Oechsel et al. Jun 2002 B1
6402055 Jaeger et al. Jun 2002 B1
6405872 Ruther et al. Jun 2002 B1
6412659 Kneer Jul 2002 B1
6419167 Fuchs Jul 2002 B1
6423298 McNamara et al. Jul 2002 B2
6427682 Klimowicz et al. Aug 2002 B1
6457658 Srinath et al. Oct 2002 B2
6464108 Corba Oct 2002 B2
6481435 Hochrainer et al. Nov 2002 B2
6491897 Freund et al. Dec 2002 B1
6503362 Bartels et al. Jan 2003 B1
6513519 Gallem Feb 2003 B2
6543448 Smith et al. Apr 2003 B1
6548647 Dietz et al. Apr 2003 B2
6550477 Casper et al. Apr 2003 B1
6565743 Poirier et al. May 2003 B1
6578741 Ritsche et al. Jun 2003 B2
6581596 Truitt et al. Jun 2003 B1
6584976 Japuntich et al. Jul 2003 B2
6606990 Stapleton et al. Aug 2003 B2
6620438 Pairet et al. Sep 2003 B2
6626309 Jansen et al. Sep 2003 B1
6640805 Castro et al. Nov 2003 B2
6641782 Mauchan et al. Nov 2003 B1
6669176 Rock Dec 2003 B2
6679254 Rand et al. Jan 2004 B1
6685691 Freund et al. Feb 2004 B1
6698421 Attolini Mar 2004 B2
6706726 Meissner et al. Mar 2004 B2
6708846 Fuchs et al. Mar 2004 B1
6725858 Loescher Apr 2004 B2
6729328 Goldemann May 2004 B2
6732731 Tseng May 2004 B1
6745763 Webb Jun 2004 B2
6779520 Genova et al. Aug 2004 B2
6789702 O'Connor et al. Sep 2004 B2
6792945 Davies et al. Sep 2004 B2
6823862 McNaughton Nov 2004 B2
6825441 Katooka et al. Nov 2004 B2
6846413 Kadel et al. Jan 2005 B1
6866039 Wright et al. Mar 2005 B1
6889690 Crowder et al. May 2005 B2
6890517 Drechsel et al. May 2005 B2
6915901 Feinberg et al. Jul 2005 B2
6929004 Bonney et al. Aug 2005 B1
6932962 Backstrom et al. Aug 2005 B1
6942127 Raats Sep 2005 B2
6964759 Lewis et al. Nov 2005 B2
6977042 Kadel et al. Dec 2005 B2
6978916 Smith Dec 2005 B2
6986346 Hochrainer et al. Jan 2006 B2
6988496 Eicher et al. Jan 2006 B1
6994083 Foley et al. Feb 2006 B2
7040311 Hochrainer et al. May 2006 B2
7066408 Sugimoto et al. Jun 2006 B2
7090093 Hochrainer et al. Aug 2006 B2
7131441 Keller et al. Nov 2006 B1
7258716 Shekarriz et al. Aug 2007 B2
7314187 Hochrainer et al. Jan 2008 B2
7331340 Barney Feb 2008 B2
7341208 Peters et al. Mar 2008 B2
7380575 Stricklin Jun 2008 B2
7417051 Banholzer et al. Aug 2008 B2
7451876 Bossi et al. Nov 2008 B2
7470422 Freund et al. Dec 2008 B2
7556037 Klein Jul 2009 B2
7559597 Mori Jul 2009 B2
7571722 Wuttke et al. Aug 2009 B2
7579358 Boeck et al. Aug 2009 B2
7611694 Schmidt Nov 2009 B2
7611709 Bassarab et al. Nov 2009 B2
7621266 Kladders et al. Nov 2009 B2
7645383 Kadel et al. Jan 2010 B2
7652030 Moesgaard et al. Jan 2010 B2
7665461 Zierenberg et al. Feb 2010 B2
7681811 Geser et al. Mar 2010 B2
7686014 Boehm et al. Mar 2010 B2
7717299 Greiner-Perth May 2010 B2
7723306 Bassarab et al. May 2010 B2
7743945 Lu et al. Jun 2010 B2
7779838 Hetzer et al. Aug 2010 B2
7802568 Eicher et al. Sep 2010 B2
7819342 Spallek et al. Oct 2010 B2
7823584 Geser et al. Nov 2010 B2
7837235 Geser et al. Nov 2010 B2
7849851 Zierenberg et al. Dec 2010 B2
7896264 Eicher et al. Mar 2011 B2
7980243 Hochrainer Jul 2011 B2
7994188 Disse Aug 2011 B2
8062626 Freund et al. Nov 2011 B2
8167171 Moretti May 2012 B2
8298622 Nakayama et al. Oct 2012 B2
8479725 Hausmann et al. Jul 2013 B2
8495901 Hahn et al. Jul 2013 B2
8650840 Holakovsky et al. Feb 2014 B2
8651338 Leak et al. Feb 2014 B2
8656910 Boeck et al. Feb 2014 B2
8733341 Boeck et al. May 2014 B2
8734392 Stadelhofer May 2014 B2
8950393 Holakovsky et al. Feb 2015 B2
8960188 Bach et al. Feb 2015 B2
9027854 Moser et al. May 2015 B2
9192734 Hausmann et al. Nov 2015 B2
9238031 Schmelzer et al. Jan 2016 B2
20010008632 Freund et al. Jul 2001 A1
20010028308 De La Huerga Oct 2001 A1
20010032643 Hochrainer et al. Oct 2001 A1
20010035182 Rubin et al. Nov 2001 A1
20020000225 Schuler et al. Jan 2002 A1
20020007155 Freund et al. Jan 2002 A1
20020046751 MacRae et al. Apr 2002 A1
20020060255 Benoist May 2002 A1
20020074429 Hettrich et al. Jun 2002 A1
20020079285 Jansen et al. Jun 2002 A1
20020092523 Connelly et al. Jul 2002 A1
20020111363 Drechsel et al. Aug 2002 A1
20020129812 Litherland et al. Sep 2002 A1
20020137764 Drechsel et al. Sep 2002 A1
20020176788 Moutafis et al. Nov 2002 A1
20030039915 Holt et al. Feb 2003 A1
20030064032 Lamche et al. Apr 2003 A1
20030066524 Hochrainer et al. Apr 2003 A1
20030085254 Katooka et al. May 2003 A1
20030098023 Drachmann et al. May 2003 A1
20030106827 Cheu et al. Jun 2003 A1
20030145849 Drinan et al. Aug 2003 A1
20030178020 Scarrott Sep 2003 A1
20030181478 Drechsel et al. Sep 2003 A1
20030183225 Knudsen Oct 2003 A1
20030187387 Wirt et al. Oct 2003 A1
20030191151 Chaudry et al. Oct 2003 A1
20030194379 Brugger et al. Oct 2003 A1
20030196660 Haveri Oct 2003 A1
20030209238 Peters et al. Nov 2003 A1
20030226907 Geser et al. Dec 2003 A1
20040004138 Hettrich et al. Jan 2004 A1
20040010239 Hochrainer et al. Jan 2004 A1
20040015126 Zierenberg et al. Jan 2004 A1
20040019073 Drechsel et al. Jan 2004 A1
20040055907 Marco Mar 2004 A1
20040060476 Sirejacob Apr 2004 A1
20040069799 Gee et al. Apr 2004 A1
20040092428 Chen et al. May 2004 A1
20040094147 Schyra et al. May 2004 A1
20040134494 Papania et al. Jul 2004 A1
20040134824 Chan et al. Jul 2004 A1
20040139700 Powell et al. Jul 2004 A1
20040143235 Freund et al. Jul 2004 A1
20040164186 Kladders et al. Aug 2004 A1
20040166065 Schmidt Aug 2004 A1
20040182867 Hochrainer et al. Sep 2004 A1
20040184994 DeStefano et al. Sep 2004 A1
20040194524 Jentzsch Oct 2004 A1
20040210199 Atterbury et al. Oct 2004 A1
20040231667 Horton et al. Nov 2004 A1
20050028815 Deaton et al. Feb 2005 A1
20050028816 Fishman et al. Feb 2005 A1
20050061314 Davies et al. Mar 2005 A1
20050089478 Govind et al. Apr 2005 A1
20050098172 Anderson May 2005 A1
20050126469 Lu Jun 2005 A1
20050131357 Denton et al. Jun 2005 A1
20050158394 Staniforth et al. Jul 2005 A1
20050159441 Hochrainer et al. Jul 2005 A1
20050183718 Wuttke et al. Aug 2005 A1
20050191246 Bechtold-Peters et al. Sep 2005 A1
20050194472 Geser et al. Sep 2005 A1
20050239778 Konetzki et al. Oct 2005 A1
20050247305 Zierenberg et al. Nov 2005 A1
20050250704 Bassarab et al. Nov 2005 A1
20050250705 Bassarab et al. Nov 2005 A1
20050255119 Bassarab et al. Nov 2005 A1
20050263618 Spallek et al. Dec 2005 A1
20050268909 Bonney et al. Dec 2005 A1
20050268915 Wassenaar et al. Dec 2005 A1
20050269359 Raats Dec 2005 A1
20060002863 Schmelzer et al. Jan 2006 A1
20060016449 Eicher et al. Jan 2006 A1
20060035874 Lulla et al. Feb 2006 A1
20060037612 Herder et al. Feb 2006 A1
20060067952 Chen Mar 2006 A1
20060086828 Bougamont et al. Apr 2006 A1
20060150971 Lee et al. Jul 2006 A1
20060196500 Hochrainer et al. Sep 2006 A1
20060225734 Sagaser et al. Oct 2006 A1
20060239886 Nakayama et al. Oct 2006 A1
20060239930 Lamche et al. Oct 2006 A1
20060279588 Yearworth et al. Dec 2006 A1
20060282045 Wilkinson et al. Dec 2006 A1
20060285987 Jaeger et al. Dec 2006 A1
20060289002 Hetzer et al. Dec 2006 A1
20060293293 Muller et al. Dec 2006 A1
20070062518 Geser et al. Mar 2007 A1
20070062519 Wuttke et al. Mar 2007 A1
20070062979 Dunne Mar 2007 A1
20070090205 Kunze et al. Apr 2007 A1
20070090576 Geser et al. Apr 2007 A1
20070107720 Boeck et al. May 2007 A1
20070119449 Boehm et al. May 2007 A1
20070137643 Bonney et al. Jun 2007 A1
20070163574 Rohrschneider et al. Jul 2007 A1
20070183982 Berkel et al. Aug 2007 A1
20070210121 Stadelhofer et al. Sep 2007 A1
20070221211 Sagalovich Sep 2007 A1
20070264437 Zimmermann et al. Nov 2007 A1
20070272763 Dunne et al. Nov 2007 A1
20070298116 Bechtold-Peters et al. Dec 2007 A1
20080017192 Southby et al. Jan 2008 A1
20080029085 Lawrence et al. Feb 2008 A1
20080060640 Waldner et al. Mar 2008 A1
20080083408 Hodson et al. Apr 2008 A1
20080092885 von Schuckmann Apr 2008 A1
20080156321 Bowman et al. Jul 2008 A1
20080197045 Metzger et al. Aug 2008 A1
20080249459 Godfrey et al. Oct 2008 A1
20080265198 Warby Oct 2008 A1
20080283553 Cox et al. Nov 2008 A1
20080299049 Stangl Dec 2008 A1
20080308580 Gaydos et al. Dec 2008 A1
20090032427 Cheu et al. Feb 2009 A1
20090060764 Mitzlaff et al. Mar 2009 A1
20090075990 Schmidt Mar 2009 A1
20090114215 Boeck et al. May 2009 A1
20090166379 Wright et al. Jul 2009 A1
20090170839 Schmidt Jul 2009 A1
20090185983 Freund et al. Jul 2009 A1
20090197841 Kreher et al. Aug 2009 A1
20090202447 Kreher et al. Aug 2009 A1
20090211576 Lehtonen et al. Aug 2009 A1
20090221626 Schmidt Sep 2009 A1
20090235924 Holakovsky et al. Sep 2009 A1
20090272664 Marshall et al. Nov 2009 A1
20090293870 Brunnberg et al. Dec 2009 A1
20090306065 Schmidt Dec 2009 A1
20090308772 Abrams Dec 2009 A1
20090314287 Spallek et al. Dec 2009 A1
20090317337 Schmidt Dec 2009 A1
20100018524 Jinks et al. Jan 2010 A1
20100018997 Faneca Llesera Jan 2010 A1
20100044393 Moretti Feb 2010 A1
20100056559 Schmelzer et al. Mar 2010 A1
20100084531 Schuchman Apr 2010 A1
20100095957 Corbacho Apr 2010 A1
20100144784 Schmelzer et al. Jun 2010 A1
20100168710 Braithwaite Jul 2010 A1
20100237102 Margheritis Sep 2010 A1
20100242557 Spreitzer et al. Sep 2010 A1
20100242954 Hahn et al. Sep 2010 A1
20100258119 Dams Oct 2010 A1
20100313884 Elliman Dec 2010 A1
20110005517 Boeck et al. Jan 2011 A1
20110041842 Bradshaw et al. Feb 2011 A1
20110168175 Dunne et al. Jul 2011 A1
20110239594 Nottingham et al. Oct 2011 A1
20110245780 Helmer et al. Oct 2011 A1
20110268668 Lamche et al. Nov 2011 A1
20110277753 Dunne et al. Nov 2011 A1
20110290239 Bach et al. Dec 2011 A1
20110290242 Bach et al. Dec 2011 A1
20110290243 Bach et al. Dec 2011 A1
20120090603 Dunne et al. Apr 2012 A1
20120132199 Kiesewetter May 2012 A1
20120138049 Wachtel Jun 2012 A1
20120138713 Schuy et al. Jun 2012 A1
20120260913 Bach et al. Oct 2012 A1
20120325204 Holakovsky et al. Dec 2012 A1
20130012908 Yeung Jan 2013 A1
20130056888 Holakovsky et al. Mar 2013 A1
20130125880 Holakovsky et al. May 2013 A1
20130125881 Holakovsky et al. May 2013 A1
20130126389 Holakovsky et al. May 2013 A1
20130206136 Herrmann et al. Aug 2013 A1
20130269687 Besseler et al. Oct 2013 A1
20140121234 Kreher et al. May 2014 A1
20140190472 Holakovsky et al. Jul 2014 A1
20140228397 Schmelzer et al. Aug 2014 A1
20140331994 Holakovsky et al. Nov 2014 A1
20150040890 Besseler et al. Feb 2015 A1
20150040893 Besseler et al. Feb 2015 A1
20150041558 Besseler et al. Feb 2015 A1
20150114387 Bach et al. Apr 2015 A1
20150122247 Besseler et al. May 2015 A1
20150258021 Kreher et al. Sep 2015 A1
20150306087 Schmelzer et al. Oct 2015 A1
20150320947 Eicher et al. Nov 2015 A1
20150320948 Eicher et al. Nov 2015 A1
20160095992 Wachtel Apr 2016 A1
Foreign Referenced Citations (310)
Number Date Country
2005201364 Jul 2006 AU
1094549 Jan 1981 CA
2233981 Apr 1997 CA
2237853 Jun 1997 CA
2251828 Oct 1997 CA
2275392 Jul 1998 CA
2297174 Feb 1999 CA
2343123 Apr 2000 CA
2434872 Aug 2002 CA
2497680 Mar 2004 CA
2513167 Oct 2004 CA
2557020 Sep 2005 CA
2653183 Dec 2007 CA
2653422 Dec 2007 CA
1125426 Jun 1996 CN
1849174 Oct 2006 CN
101247897 Aug 2008 CN
1653651 Jul 1971 DE
2754100 Jun 1978 DE
4117078 Nov 1992 DE
19625027 Jan 1997 DE
19615422 Nov 1997 DE
19653969 Jun 1998 DE
19902844 Nov 1999 DE
10007591 Nov 2000 DE
10104367 Aug 2002 DE
10300983 Jul 2004 DE
102004031673 Jan 2006 DE
202006017793 Jan 2007 DE
01102006025871 Dec 2007 DE
83175 Jul 1957 DK
140801 Nov 1979 DK
0018609 Nov 1980 EP
0289332 Nov 1988 EP
0289336 Nov 1988 EP
0354507 Feb 1990 EP
0364235 Apr 1990 EP
0372777 Jun 1990 EP
0386800 Sep 1990 EP
0412524 Feb 1991 EP
0505123 Sep 1992 EP
0520571 Dec 1992 EP
0622311 Nov 1994 EP
0642992 Mar 1995 EP
0679443 Nov 1995 EP
0735048 Oct 1996 EP
0811430 Mar 1997 EP
0778221 Jun 1997 EP
0845253 Jun 1998 EP
0845265 Jun 1998 EP
0860210 Aug 1998 EP
0916428 May 1999 EP
0965355 Dec 1999 EP
0970751 Jan 2000 EP
1003478 May 2000 EP
1017469 Jul 2000 EP
1025923 Aug 2000 EP
1068906 Jan 2001 EP
1075875 Feb 2001 EP
1092447 Apr 2001 EP
1157689 Nov 2001 EP
1211628 Jun 2002 EP
1245244 Oct 2002 EP
1312418 May 2003 EP
1375385 Jan 2004 EP
1521609 Apr 2005 EP
1535643 Jun 2005 EP
1595564 Nov 2005 EP
1595822 Nov 2005 EP
1726324 Nov 2006 EP
1736193 Dec 2006 EP
1795221 Jun 2007 EP
1813548 Aug 2007 EP
2135632 Dec 2009 EP
2262348 Nov 2006 ES
2505688 Nov 1982 FR
2604363 Apr 1988 FR
2673608 Sep 1992 FR
2756502 Jun 1998 FR
1524431 Sep 1978 GB
2081396 Feb 1982 GB
2101020 Jan 1983 GB
2279273 Jan 1995 GB
2291135 Jan 1996 GB
2332372 Jun 1999 GB
2333129 Jul 1999 GB
2347870 Sep 2000 GB
2355252 Apr 2001 GB
2398253 Aug 2004 GB
0700839.4 Jul 2008 GB
S5684246 Jul 1981 JP
H01288265 Nov 1989 JP
H0228121 Jan 1990 JP
H057246 Feb 1993 JP
H0553470 Mar 1993 JP
H06312019 Nov 1994 JP
H07118164 May 1995 JP
H07118166 May 1995 JP
07323086 Dec 1995 JP
H08277226 Oct 1996 JP
H092442 Jan 1997 JP
H0977073 Mar 1997 JP
H09315953 Dec 1997 JP
2001518428 Oct 2001 JP
2001346878 Dec 2001 JP
2002504411 Feb 2002 JP
2002235940 Aug 2002 JP
2003511212 Mar 2003 JP
2003299717 Oct 2003 JP
2004502502 Jan 2004 JP
2004097617 Apr 2004 JP
2005511210 Apr 2005 JP
2005144459 Jun 2005 JP
2007517529 Jul 2007 JP
2007245144 Sep 2007 JP
2007534379 Nov 2007 JP
2008119489 May 2008 JP
2008541808 Nov 2008 JP
2010526620 Aug 2010 JP
2010540371 Dec 2010 JP
198100674 Mar 1981 WO
198200785 Mar 1982 WO
198300288 Feb 1983 WO
198303054 Sep 1983 WO
198605419 Sep 1986 WO
198706137 Oct 1987 WO
198803419 May 1988 WO
198900889 Feb 1989 WO
198900947 Feb 1989 WO
198902279 Mar 1989 WO
198903672 May 1989 WO
198903673 May 1989 WO
198905139 Jun 1989 WO
199009780 Sep 1990 WO
199009781 Sep 1990 WO
1991014468 Oct 1991 WO
199206704 Apr 1992 WO
199217231 Oct 1992 WO
199221332 Dec 1992 WO
199222286 Dec 1992 WO
1993013737 Jul 1993 WO
199325321 Dec 1993 WO
1993024164 Dec 1993 WO
9407607 Apr 1994 WO
199417822 Aug 1994 WO
199425371 Nov 1994 WO
199427653 Dec 1994 WO
199503034 Feb 1995 WO
1995032015 Nov 1995 WO
199600050 Jan 1996 WO
1996006011 Feb 1996 WO
199606581 Mar 1996 WO
199623522 Aug 1996 WO
199701329 Jan 1997 WO
199706813 Feb 1997 WO
199706842 Feb 1997 WO
199712683 Apr 1997 WO
1997012687 Apr 1997 WO
199720590 Jun 1997 WO
199723208 Jul 1997 WO
199727804 Aug 1997 WO
199735562 Oct 1997 WO
199741833 Nov 1997 WO
1998012511 Mar 1998 WO
199827959 Jul 1998 WO
199831346 Jul 1998 WO
199839043 Sep 1998 WO
1999001227 Jan 1999 WO
1999007340 Feb 1999 WO
1999011563 Mar 1999 WO
1999016530 Apr 1999 WO
1999043571 Sep 1999 WO
199962495 Dec 1999 WO
199965464 Dec 1999 WO
200001612 Jan 2000 WO
200023037 Apr 2000 WO
2000023065 Apr 2000 WO
200027543 May 2000 WO
200037336 Jun 2000 WO
2000033965 Jun 2000 WO
200049988 Aug 2000 WO
200064779 Nov 2000 WO
200113885 Mar 2001 WO
200128489 Apr 2001 WO
2001064182 Sep 2001 WO
200187392 Nov 2001 WO
2001085097 Nov 2001 WO
200197888 Dec 2001 WO
200198175 Dec 2001 WO
200198176 Dec 2001 WO
200204054 Jan 2002 WO
200205879 Jan 2002 WO
WO 0216046 Feb 2002 WO
200217988 Mar 2002 WO
200232899 Apr 2002 WO
2002034411 May 2002 WO
2002070141 Sep 2002 WO
2002089887 Nov 2002 WO
2003002045 Jan 2003 WO
2003014832 Feb 2003 WO
2003020253 Mar 2003 WO
2003022332 Mar 2003 WO
2003035030 May 2003 WO
2003037159 May 2003 WO
2003037259 May 2003 WO
2003049786 Jun 2003 WO
2003050031 Jun 2003 WO
2003053350 Jul 2003 WO
2003057593 Jul 2003 WO
2003059547 Jul 2003 WO
2003068299 Aug 2003 WO
2003087097 Oct 2003 WO
2003097139 Nov 2003 WO
2004019985 Mar 2004 WO
2004022052 Mar 2004 WO
2004022132 Mar 2004 WO
2004022244 Mar 2004 WO
2004024157 Mar 2004 WO
200433954 Apr 2004 WO
2004062813 Jul 2004 WO
2004078236 Sep 2004 WO
2004089551 Oct 2004 WO
2004091704 Oct 2004 WO
2004098689 Nov 2004 WO
2004098795 Nov 2004 WO
2005000476 Jan 2005 WO
2005004844 Jan 2005 WO
2005014175 Feb 2005 WO
2005020953 Mar 2005 WO
2005030211 Apr 2005 WO
2005055976 Jun 2005 WO
2005077445 Aug 2005 WO
2005079997 Sep 2005 WO
2005080001 Sep 2005 WO
2005080002 Sep 2005 WO
2005087299 Sep 2005 WO
2005107837 Nov 2005 WO
2005109948 Nov 2005 WO
2005112892 Dec 2005 WO
2005112996 Dec 2005 WO
2005113007 Dec 2005 WO
2006011638 Feb 2006 WO
2006018392 Feb 2006 WO
2006027595 Mar 2006 WO
2006037636 Apr 2006 WO
2006037948 Apr 2006 WO
2006042297 Apr 2006 WO
2006045813 May 2006 WO
2006110080 Oct 2006 WO
2006125577 Nov 2006 WO
2006126014 Nov 2006 WO
2007011475 Jan 2007 WO
2007022898 Mar 2007 WO
2007049239 May 2007 WO
2007060104 May 2007 WO
2007060105 May 2007 WO
2007060106 May 2007 WO
2007060107 May 2007 WO
2007060108 May 2007 WO
2007062721 Jun 2007 WO
2007090822 Aug 2007 WO
2007101557 Sep 2007 WO
2007128381 Nov 2007 WO
2007134965 Nov 2007 WO
2007134966 Nov 2007 WO
2007134967 Nov 2007 WO
2007134968 Nov 2007 WO
2007141201 Dec 2007 WO
2007141203 Dec 2007 WO
2008023017 Feb 2008 WO
2008047035 Apr 2008 WO
2008077623 Jul 2008 WO
2008124666 Oct 2008 WO
2008138936 Nov 2008 WO
2008146025 Dec 2008 WO
2009006137 Jan 2009 WO
2009047021 Apr 2009 WO
2009047173 Apr 2009 WO
2009050978 Apr 2009 WO
2009090245 Jul 2009 WO
2009103510 Aug 2009 WO
2009115200 Sep 2009 WO
2010005946 Jan 2010 WO
2010006870 Jan 2010 WO
2010094305 Aug 2010 WO
2010094413 Aug 2010 WO
2010112358 Oct 2010 WO
2010133294 Nov 2010 WO
2011006711 Jan 2011 WO
2011064160 Jun 2011 WO
2011064163 Jun 2011 WO
2011064164 Jun 2011 WO
2011131779 Oct 2011 WO
2011154295 Dec 2011 WO
2011160932 Dec 2011 WO
2012130757 Oct 2012 WO
2012159914 Nov 2012 WO
2012160047 Nov 2012 WO
2012160052 Nov 2012 WO
2012161685 Nov 2012 WO
2012162305 Nov 2012 WO
2013110601 Aug 2013 WO
2013152861 Oct 2013 WO
2013152894 Oct 2013 WO
2015018901 Feb 2015 WO
2015018903 Feb 2015 WO
2015018904 Feb 2015 WO
2015169431 Nov 2015 WO
2015169732 Nov 2015 WO
199901520 Dec 1999 ZA
Non-Patent Literature Citations (52)
Entry
Cras et al “Comparison of chemical cleaning methods of glass in preparation for silanization” Biosensors & Bioelectronics 14 (1999) 683-688.
Hoffman et al “Mixed self-assembled monolayers (SAMs) consisting of mehyoxy-tri(ethylene glycol)-terminated and alkyl-terminated dimethylchlorosilanes control the non-specific adsorption of proteins at oxidic surfaces” J. of Colloid and Interface Science 295 (2006) 427-435.
Husseini et al “Alkyl Monolayers on Silica Surfaces Prepared Using Neat, Heated Dimethylmonochlorosilanes with Low Vapor Pressures” Langmuir 2003, 19, 5169-5171.
Elwenspoek et al, Mechanical Microsensors, Springer-Verlag Berlin Heidelberg (c) 2001 4 pages.
Kutchoukov et al “Fabrication of nanofluidic devices using glass-to-glass anodic bonding” Sensors and Actuators A 114 (2004) p. 521-527.
Mandel et al “Cytophobic surface modification of microfluidic arrays for in situ parallel peptide synthesis and cell adhesion assays” Biotechnol Prog. Author manuscript available in PMC Sep. 21, 2008 19 pgs.
Wang et al “Self-Assembled Silane Monolayers: Fabrication with Nanoscale Uniformity”; Langmuir 2005, 21, 1848-1857.
Ackermann et al.; Quantitative Online Detection of Low-Concentrated Drugs via a SERS Microfluidic System; ChemPhysChem; 2007; vol. 8; No. 18; pp. 2665-2670.
Wang et al.; Self-Assembled Silane Monolayers: Fabrication with Nanoscale Uniformity; Langmuir; 2005; vol. 21; No. 5; pp. 1848-1857.
Henkel et al.; Chip modules for generation and manipulation of fluid segments for micro serial flow processes; Chemical Engineering Journal; 2004; vol. 101; pp. 439-445.
Han et al.; Surface activation of thin silicon oxides by wet cleaning and silanization; Thin Solid Films; 2006; vol. 510; No. 1-2; pp. 175-180.
International Search Report, Form PCT/ISA/210, for corresponding PCT/EP2010/053668; dated Nov. 8, 2010.
“Lung Cancer”. Merck Manual Home Edition, pp. 1-7. [Accessed at www.merck.com/mmhe/print/sec04/ch057/ch057a.html, on Jul. 28, 2010].
Abstract in English for DE19902844, 1999.
Abstract in English for DE4117078, 1992.
Abstract in English for EP0354507, 1990.
Abstract in English for FR2756502, 1998.
Abstract in English for JPS5684246, 1979.
Abstract in English of DE10007591, 2000.
Abstract in English of DE202006017793, 2007.
Abstract in English of JPH07118164, 1995.
Abstract in English of JPH07118166, 1995.
Abstract in English of JPH08277226,1996.
Abstract in English of JPH092442, 1997.
Abstract in English of JPH09315953, 1997.
Abstract in English of JPH0977073, 1997.
Abstract in English of WO199706813, 1997.
Abstract in English of WO199839043, 1998.
Abstract in English of WO2002070141, 2002.
Bocci et al., “Pulmonary catabolism of interferons: alveolar absorption of 125I-labeled human interferon alpha is accompanied by partial loss of biological activity”. Antiviral Research, vol. 4, 1984, pp. 211-220.
China Suppliers, Shanghai Lite Chemical Technology Co., Ltd. Product details on polyvinylpyrrolidones. Obtained online by the USPTO examiner on Apr. 24, 2011.
Diamond et al., “Substance P Fails to Mimic Vagally Mediated Nonadrenergic Bronchodilation”. Peptides, vol. 3, 1982, pp. 27-29.
English Language Abstract of EP1068906, 2001.
Fuchs et al., “Neopterin, biochemistry and clinical use as a marker for cellular immune reactions”. International Archives of Allergy and Immunology, vol. 101, No. 1, 1993, pp. 1-6, Abstract 1p.
Ip et al., “Stability of Recombinant Consensus Interferon to Air-Jet and Ultrasonic Nebulization”. Journal of Pharmaceutical Sciences, vol. 84, No. 10, Oct. 1995, pp. 1210-1214.
Jendle et al., “Intrapulmonary administration of insulin to healthy volunteers”. Journal of Internal Medicine, vol. 240, 1996, pp. 93-98.
Lougheed et al., “Insulin Aggregation in Artificial Delivery Systems”. Diabetologia, vol. 19, 1980, pp. 1-9.
Niven et al., “Some Factors Associated with the Ultrasonic Nebulization of Proteins”. Pharmaceutical Research, vol. 12, No. 1, 1995, pp. 53-59.
Remington Pharmacy, Editor Alfonso R. Gennaro. 19th ed., Spanish Secondary Edition: Panamericana, Spain, 1995, Sciarra, J.J., “Aerosols”, pp. 2560-2582. The English translation is from the 1995 English Primary Edition, Sciarra, J.J., Chapter 95, R97-1185.
Trasch et al., “Performance data of refloquant Glucose in the Evaluation of Reflotron”. Clinical Chemistry, vol. 30, 1984, p. 969 (abstract only).
Wall et al., “High levels of exopeptidase activity are present in rat and canine bronchoalveolar lavage fluid”. International Journal of Pharmaceutics, vol. 97, Issue 1-3, pp. 171-181, 1993, Abstract pp. 1-2.
Abstract in English of JPH057246, 1993.
Abstract in English of JPH0553470, 1993.
Chen, F-K et al., “A study of forming pressure in the tube-hydroforming process”. Journal of Materials Processing Technology, 192-193, 2007, p. 404-409.
Abstract in English of FR2604363, Sep. 30, 1986.
“Activate”. Collins English Dictionary, London: Collins, 2000, 2 pages. [Retrieved at http://search.credoreference.com/content/entry/hcengdict/activate/0 on Jun. 12, 2014].
Beasley R et al: “Preservatives in Nebulizer solutions: Risks without Benefit” Pharmacotherapy, Boston, US, Bd. 18, Nr. 1, Jan. 1998, pp. 130-139.
Beasley R et al: “Preservatives in Nebulizer solutions: Risks without Benefit” Pharmacotherapy, Boston, US, Bd. 18, Nr. 1, Jan. 1998.
JP2005144459—English language abstract only.
Abstract in English for WO2009050978, 2009.
Abstract in English for JP2002-235940, 2001.
Myung-Suk Chun et al, “Fabrication and validation of a multi-channel type microfluidic chip for electronical streaming potential devices”, Lab on a Chip: miniaturisation for chemistry, physics, biology, materials science and bioengineering, 2006, vol. 6, No. 2, pp. 302-309.
Related Publications (1)
Number Date Country
20120138713 A1 Jun 2012 US